WELL Health financial statements provide useful quarterly and yearly information to potential WELL Health Technologies investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on WELL Health financial statements helps investors assess WELL Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting WELL Health's valuation are summarized below:
Gross Profit
422.9 M
Profit Margin
0.0767
Market Capitalization
1.3 B
Enterprise Value Revenue
1.6966
Revenue
957.7 M
We have found one hundred twenty available fundamental gauges for WELL Health Technologies, which can be analyzed and compared to other ratios and to its peers. Self-guided Investors are advised to confirm WELL Health's prevalent fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself next year. As of the 19th of March 2025, Market Cap is likely to grow to about 860.6 M. Also, Enterprise Value is likely to grow to about 1.2 B
WELL Health investors utilize fundamental indicators, such as revenue or net income, to predict how WELL Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
WELL Health financial ratios help investors to determine whether WELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WELL with respect to the benefits of owning WELL Health security.